Le Lézard
Classified in: Health, Business
Subjects: LIC, CXP

ReFocus Eye Health Strengthens Presence in New Jersey with Eight Premier Practice Partnerships


STAMFORD, Conn., Feb. 22, 2024 /PRNewswire/ -- ReFocus Eye Health proudly announces its latest expansion with the addition of eight distinguished ophthalmology practices across northern New Jersey. This newly formed partnership represents a transformational milestone for ReFocus Eye Health as it advances its mission to preserve the independence and clinical autonomy of leading eye care providers while facilitating continued access to quality care and excellent patient service.

Backed by Zenyth Partners, ReFocus Eye Health is a leading, comprehensive eye care management services organization based in the Northeast US. ReFocus provides best-in-class administrative support to its affiliated practices and physicians, enabling them to focus expressly on providing high-quality, personalized patient care.

The following practices have joined ReFocus Eye Health's consortium of affiliated physicians:

  1. Advanced Eye Care Center
  2. Alden Leifer, MD and Associates
  3. Associated Eye Physicians & Surgeons of New Jersey
  4. Diane M. Hilal-Campo, MD
  5. EyeCare Consultants of NJ
  6. Retina Associates of North West New Jersey
  7. Retina Consultants
  8. Westwood Ophthalmology Associates

Each practice possesses a unique expertise and commitment to excellence, aligning seamlessly with ReFocus Eye Health's vision of enabling the highest standards of care.

"We carefully considered all options and ultimately chose ReFocus because of their unwavering commitment to clinical autonomy and their collaborative, doctor-friendly partnership approach ? each of which is of paramount importance to us," said Dr. Kirk Tchorbajian of Associated Eye Physicians & Surgeons of New Jersey.

"This partnership with ReFocus represents an exciting new frontier for our practice. With their support, we are confident in our ability to continue growing and serving our community with the highest standards of care for years to come," added Dr. Jai Parekh of EyeCare Consultants of NJ.

"We're delighted to welcome these esteemed practices to the ReFocus Eye Health family," remarked Jeff Rinkov, CEO of ReFocus. "Their success is rooted in prioritizing what truly matters: their patients. This patient-centric ethos mirrors the foundation of ReFocus. We eagerly anticipate providing unwavering support to our new affiliated physicians and team members as we embark on this next phase of growth."

About ReFocus Eye Health:
ReFocus Eye Health is a management services organization (MSO) supporting a comprehensive, multi-specialty community of vision care providers. ReFocus Eye Health provides non-clinical support services to its affiliated practices, enabling physicians to focus exclusively on patient care. ReFocus now supports a total of 62 locations and more than 140 ophthalmologists / optometrists spanning DC, MD, PA, NJ, CT, MA and RI. For more information, please visit www.refocuseyedoctors.com.

About Zenyth Partners:
Zenyth Partners is an operationally focused investment firm focused exclusively on building leading healthcare companies. Zenyth Partners collaborates with entrepreneurs, clinicians, and operators that share similar values, creating differentiated healthcare organizations that support patients, providers, payors, and the community at large. For more information, please visit?www.zenythpartners.com.

Media Contact:
Zvi Pardes
Sr. Marketing Manager
Email: zvi.pardes@refocuseye.com

SOURCE ReFocus Eye Health


These press releases may also interest you

at 04:00
King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have...

at 04:00
IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference...

at 03:43
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell analysis of the fully human...

at 03:37
RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company's innovative treatment planning system. The new version comes with automation of important clinical workflows, such as automatic image...

at 03:15
TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer's disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive...

at 03:00
Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its...



News published on and distributed by: